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Abstract
Background—Increasing regulation of medical research, in particular the requirement for
explicit consent, may reduce the quantity and quality of clinical epidemiological research.
Aim—To assess the potential biases arising from the need for explicit consent in our hospital-
based stroke research register.
Design—Comparison of patients enrolled into our stroke research register with those included in
a concurrent clinical stroke audit that targeted the same population but did not require explicit
consent.
Methods—We obtained the numbers of consenters, refusers, and those from whom consent was
not sought for various logistical reasons. We compared characteristics of participants (those
eventually included in the research register) versus non-participants.
Results—Of 1228 patients included in the stroke audit during an 18-month period, 1075 (88%)
were also included in the research register, with higher participation among outpatients than
inpatients. Only 1% of eligible patients refused involvement in any aspect of the research register.
By far the largest number of non-participants was those from whom we could not seek consent for
practical reasons. Comparison of baseline characteristics showed important differences between
participants and non-participants that could affect outcome.
Conclusions—Very few patients refused inclusion in our research register, but the need for
explicit consent reduced participation and introduced bias. An opt-out system avoiding the need
for explicit patient consent for minimally intrusive clinical epidemiological studies would
minimise bias and reduce the considerable time and costs associated with the consent process.
In recent years, medical research in the UK and elsewhere has become more and more
regulated. In particular, increasingly stringent requirements for explicit consent from
patients for the collection or use of their medical data for research have had a substantial
impact on observational epidemiological research, increasing the time and resources
required, and introducing the potential for ‘consent bias’.1 Thus, although designed to
Correspondence to Dr Cathie Sudlow, cathie.sudlow@ed.ac.uk.
Author contributions: Caroline Jackson co-ordinated the stroke research register, carried out statistical analyses, prepared figures
and tables, and wrote the paper. Laura Crossland checked and analysed data, helped to prepare figures, and commented on earlier
drafts of the paper. Martin Dennis coordinates the stroke audit, contributed clinical and research expertise to the stroke register, and
commented on earlier drafts of the paper. Joanna Wardlaw contributed neuroradiological and research expertise to the audit and stroke
register, and commented on earlier drafts of the paper. Cathie Sudlow is principal investigator for and co-ordinated the research
register, supervised data analyses and co-wrote the paper.
Conflict of interest: None of the authors has any conflict of interest in relation to this manuscript.
Europe PMC Funders Group
Author Manuscript
QJM. Author manuscript; available in PMC 2008 October 17.
Published in final edited form as:
QJM. 2008 April ; 101(4): 281–289. doi:10.1093/qjmed/hcm152.
 Europe PM
C Funders A
uthor M
anuscripts
 Europe PM
C Funders A
uthor M
anuscripts
protect individuals, requiring explicit consent may seriously reduce the quality and quantity
of observational clinical research, with reduced benefits for society.
In the UK alone, there is an increasing body of complex legislation relating to the use of
healthcare information (Table 1).2-8 Interpretation of the relevant acts of parliament is far
from straightforward, and is made more challenging by the frequent introduction of new
legislation, some of which differs north (Scotland) and south (England and Wales) of the
border. The UK Data Protection Act 1998 makes exemptions from the need for explicit
consent for some forms of medical research,5 while the Health and Social Care Act 2001
allows for the use of identifiable data without patients' explicit consent in particular
restricted circumstances, but it applies only to England and Wales (not Scotland).2
Ambiguities in interpretation of the law and fear of legal actions have generally led to
restrictive guidance by professional bodies (Table 1), so that explicit consent for
observational research has become the default requirement for most regulatory bodies and
research ethics committees, particularly for identifiable patient data.
Research involving patients unable to consent for themselves (e.g., because of dysphasia,
cognitive impairment or reduced conscious level due to stroke), is particularly constrained
by current legislation and guidance. Current UK legislation does permit proxy consent from
relatives or legal guardians, but time and resource limitations can make this logistically
challenging to obtain, and there is a lack of clear guidance on inclusion of patients for whom
there are no substitute decision makers available. The Adults with Incapacity (Scotland) Act
2000, introduced early in the course of the research project described in this paper, does not
allow for consent to participate in medical research by an impartial medical representative
(waiver of consent) in these situations,3 but the Mental Capacity Act 2005 (England &
Wales) permits such waiver of consent for research that is not ‘unduly invasive or
restrictive’.4 In practice, the interpretation of the law currently resides with research ethics
committees, and the onus has fallen on researchers to provide empirical evidence of the
practical and scientific problems produced by the requirement for explicit consent.9
In this study, we were able to take advantage of a double standard in the UK, whereby
explicit consent is usually required for observational clinical research but not for clinical
audit.10 We assessed the impact of the consent process in our hospital-based stroke research
register through comparisons with a concurrent clinical stroke audit, which did not require
explicit consent. We sought consent not only for the use of clinical data for research
purposes, but also to obtain a research blood sample and for follow-up by questionnaire, and
so were able to assess patients' willingness to participate in non-intrusive - as well as in
somewhat intrusive - aspects of our research register.
Methods
In our ongoing stroke audit, we collect data on process of care and key clinical variables on
all patients with a stroke or transient ischaemic attack (TIA) admitted to - or seen in
outpatient clinics at - an Edinburgh teaching hospital, with no requirement for explicit
consent. Administrative and nursing staff in the audit team identify patients using
comprehensive, multiple, overlapping, prospective and retrospective methods.
From October 2002 through March 2004, we collected additional data on patients from the
same target population who consented to inclusion in our research register as well as from
those whose data were not covered by the UK Data Protection Act 1998 because they died
during admission. We used multiple, overlapping, prospective methods to identify patients,
and discussed and clarified the clinical details and brain imaging findings of the patients
included in the research register at a weekly meeting attended by stroke doctors and
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neuroradiologists. A team of consultant geriatricians and neurologists, stroke registrars and
stroke research fellows assessed the patients and sought consent from eligible patients
during their time in hospital, with up to five such doctors involved in recruiting patients into
the study at any one point in time.
Outpatients were given a brief, easily readable patient information leaflet describing the
study, along with a short consent form, with time to read and consider these before the
consultation with the clinic doctor. Patients who wanted further time to consider consenting
for the study were given the option of returning the consent form to the study team by post.
Inpatients (and / or their relatives) were provided with a similar information leaflet during
their hospital stay, and given time to consider the information before being asked for
consent. Patients gave signed consent, or - if unable to write but still able to understand -
verbal consent signed by a witness. For patients with incapacity, we sought signed proxy
consent from a relative whenever possible. We initially had research ethics committee
approval for waiver of consent in some situations (patients with incapacity but no available
proxy and patients who were seriously ill and died before consent could be sought), but the
introduction of the Adults with Incapacity (Scotland) Act a few months after recruitment
started meant that we could no longer recruit living, incapacitated patients with no available
proxy. Patients (or their proxies) could consent to any or all of four subcategories, allowing
us to: use their clinical data for research; obtain additional information from their family
doctor; contact them in the future for follow-up by postal questionnaire; and store a sample
of their blood for future genetic and other biological analyses. We obtained Multicentre
Research Ethics Committee approval for the audit (as part of a Scotland-wide stroke audit)
and Local Research Ethics Committee approval for the research register.
Numbers of consenters, refusers, and participants
For the period October 2002 through March 2004, we obtained the total number of patients
with a stroke or TIA included in the audit. Of these, we determined the number who: were
approached and gave consent for inclusion in the research register; refused consent; or were
not approached for consent because they died in hospital before consent could be sought,
were not identified prospectively by the stroke register, or were identified prospectively but
not approached for consent for logistical reasons. Among consenters, we calculated the
proportion with consent direct from the patient or from a relative. Among those from whom
we sought consent, we calculated the proportion giving consent to each of the four consent
subcategories. We defined and enumerated ‘participants’ as those included in the research
register (i.e. those who gave consent and those who died in hospital before consent could be
sought), and ‘non-participants’ as those not included in the research register (those who
refused consent and those from whom consent was not sought, excluding those who died in
hospital before consent could be sought).
Characteristics of participants versus non-participants
We assessed differences between participants and non-participants, comparing variables that
had been collected by both the audit and the research register: age; sex; event subtype
(cerebral transient ischaemic attack [TIA], eye attack [transient monocular blindness or
retinal artery occlusion], or stroke classified according to the Oxfordshire Community
Stroke Project syndromes11); socio-economic deprivation (using the Carstairs deprivation
index12) and (for inpatients only) admission to stroke unit and length of stay. We performed
statistical analyses with STATA (version 8.0). We analysed data for inpatients and
outpatients separately, using the Mantel-Haenszel χ2 test for categorical variables, and t-test
for continuous variables. We adjusted for potential confounding by including all the
variables in logistic regression models. We considered a p value of ≤ 0.05 to be statistically
significant.
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Results
Numbers of consenters, refusers, and participants
Of 1228 patients included in the audit and so eligible for the research register, the research
register team prospectively identified 1199 (98%), and 1075 of the 1228 (88%) eventually
participated in the research register (Figure 1). 1061 patients were approached for consent
and we obtained consent from 1050 of these. 25 patients died in hospital before consent
could be sought and were also included as participants. Of those from whom we obtained
consent, 94% gave their own consent, and proxy consent from relatives accounted for the
remaining 6%. There were 153 non-participants (12% of the 1228 patients included in the
audit). Non-participants comprised: 11 of 1228 eligible patients (1%) who refused consent;
29 (2%) who were not identified prospectively by the research register but were picked up
by the audit; and 113 (9%) identified by the stroke register but from whom consent was not
sought (Figure 1). Reasons for not seeking consent from identified patients included
discharge from hospital before consent could be sought by one of the research register team,
and inability to meet with and obtain signed consent from relatives of patients who were
unable to consent for themselves.
The proportion of patients from whom we sought and obtained consent was higher among
outpatients than inpatients, resulting in higher participation rates in outpatients than in
inpatients (697/731 [95%] vs 378/497 [76%], p<0.001) (Figure 2). Of the 1061 patients
approached for consent, 1050 (99%) consented to use of their clinical data for research,
1048 (99%) to contact with their family doctor, 1031 (97%) to future direct contact for
follow-up, and 1021 (96%) to storage of a blood sample.
Characteristics of participants versus non-participants
The characteristics of the 1075 participants and 153 non-participants are presented
separately for inpatients and outpatients in Tables 2 and 3. Overall mean age was about 70
years, with approximately equal numbers of men and women, and no significant differences
between participants and non-participants in age or gender. However, there were differences
in other characteristics, particularly for inpatients, among whom participants were
significantly more likely than non-participants to be admitted to a stroke unit (77% versus
45%, adjusted p value < 0.001), and to be more affluent (adjusted p value for trend across
socioeconomic strata = 0.01). The unadjusted distribution of event type among inpatients
also differed significantly between participants and non-participants (p = 0.001): participants
had a smaller proportion of TIAs and eye attacks, a greater proportion of mild (lacunar or
partial anterior circulation) strokes, and a slightly greater proportion of the most severe (total
anterior circulation) strokes (Figure 3). However, the relationship became non-significant (p
= 0.08) after adjusting for the other variables (Table 2).
Differences between participants and non-participants were less striking for outpatients,
among whom the number and proportion of non-participants was small (34/731 = 5%)
(Figure 2, Table 3). The only statistically significant difference (in both univariate and
adjusted analyses) between participants and non-participants among outpatients was in the
distribution of event type (Figure 3, Table 3).
The number of patients who refused consent (n=11) was too small to perform any
meaningful comparison of characteristics with consenters.
Discussion
Our comparison between a stroke research register requiring explicit, written consent and a
contemporaneous stroke audit not requiring explicit consent found that 88% of eligible
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patients identified in the audit participated in the research register. A very small proportion
of patients refused consent to be included in our research register (1% of those approached
for consent, and < 1% of eligible patients); the main cause of non-participation was our
inability to seek consent from 9% of eligible patients because of practical barriers. Almost
all patients approached (99%) gave consent to use of their clinical data for research or
contact with their family doctor, while only slightly fewer consented to questionnaire
follow-up (98%) or storage of a blood sample for research analyses (96%). Consent rates
were therefore very little affected by the additional request to obtain more intrusive data
(questionnaire follow-up information and a research blood sample) not sought as part of
routine clinical care. Thus, the logistical hurdles associated with the requirement to seek
explicit consent, rather than patients' unwillingness to participate, was the main determinant
of incomplete participation in the stroke register.
The very low refusal rate in our study would seem to reflect the willingness of this group of
patients to participate in both entirely non-intrusive and somewhat intrusive aspects of
observational clinical research. The refusal rate may have been minimised by the use of
clear, brief, easily readable information leaflets and consent forms, and by consent being
sought by doctors, on a background of good doctor-patient relationships. It may also partly
reflect the patients' characteristics, including for example their age and cultural setting, as
well as their perception of the seriousness of their condition and the need for research to
improve our understanding of and treatments for stroke.
Contacting patients for follow-up by postal questionnaire and obtaining a blood sample
would generally be considered intrusive. However, the very low refusal rates even for these
components of our research register would suggest that the majority of patients in our study
did not consider them an unwelcome intrusion. Indeed, with respect to the follow-up
questionnaire, although not formally analysed for the purposes of this study, return rates
were high (over 85% of questionnaires sent out were completed and returned), informal
comments on the returned forms indicated that most patients and/or proxies were very happy
that someone was interested in how they were getting on since their stroke, and only 4
patients (out of more than 1000 sent a questionnaire) asked that no further questionnaire be
sent . With respect to blood sampling, although this is invasive, the risk of harm to the
patient from the withdrawal of a small volume (a few mls) of peripheral venous blood is
minimal. Furthermore, in a study such as ours, collection of a blood sample for research
could quite feasibly be done at the same time as blood is taken for routine clinical
investigations, minimising the invasiveness of this aspect of the study. We found evidence
that the incomplete participation in our research register introduced potential bias, with
important differences between participants and non-participants, which can mainly be
explained by the practicalities of the consent process. Participants were more likely than
non-participants to be outpatients, and so to have milder events, since it was relatively
straightforward to seek consent from outpatients as a standard part of the clinic procedure,
and more difficult to streamline the process for inpatients. Inpatient participants were more
likely than non-participants to be admitted to a stroke unit (which we know from
randomised trials leads to better outcomes13), reflecting the practical difficulties of
obtaining consent from patients admitted to outlying wards in different parts of the hospital.
The smaller proportion of TIA patients among participants reflects the difficulties in
obtaining consent from patients with very mild events, who are often admitted to hospital for
a short time only. The larger proportion of milder (lacunar and partial anterior circulation)
strokes among participants compared with non-participants suggests that it was easier to
obtain consent from patients with milder events, who were likely to be admitted for a long
enough duration to be approached for their consent, and then to be able to consent for
themselves, rather than having to wait for a relative to be available. The larger proportion of
patients with very severe (total anterior circulation) strokes among participants could be
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explained by their relatively high early case fatality11 coupled with our ability to include in
the research register those patients who died in hospital before consent could be sought.
Although there were statistically significant differences in the distribution of events among
outpatients for participants versus non-participants, these did not follow an easily
explainable pattern, perhaps because events among outpatients were mostly mild, and the
number (n = 34) of non-participants was small.
Study limitations
First, the baseline characteristics that we could compare between participants and non-
participants were restricted to variables collected by both the audit and the research register,
using comparable methods and definitions. Second, we were unable to assess whether there
were any differences in outcome between participants and non-participants, since patients
identified by the audit are not routinely followed for further events.
Comparisons with other recent studies
Several other groups have reported on the practical difficulties of obtaining consent in
various clinical epidemiological settings, important baseline differences between consenters
and non-consenters, and serious outcome bias as a result of the requirement for explicit
consent.1,14-17 One other study has investigated patient participation in a hospital-based
stroke register. This was a multicentre Canadian study, in which the target population was
all inpatient admissions for stroke15 The refusal rate (12% of eligible patients) was much
higher and the overall proportion of eligible patients included (51%) much lower than in our
study, even compared with only the inpatients in our register. These differences could have
been due to: the added complexities of obtaining consent in a multicentre register compared
with our single centre study; variation between the studies in the administrative demands of
the consent process, and the resources available to meet them; research nurses rather than
doctors seeking consent in the Canadian study; and perhaps cultural differences between the
Scottish and Canadian populations. Notwithstanding the differences, the Canadian study
also demonstrated that the practical difficulties in obtaining consent rather than explicit
refusal was the main determinant of incomplete participation, and found differences between
participants and non-participants in baseline characteristics and in-hospital mortality,
suggesting that participants had milder strokes.
Conclusions and recommendations
Very few patients refused to be included in our stroke research register, but processes
integral to the requirement for explicit consent reduced participation and introduced bias.
Ideally, complete participation in observational research such as this is desirable to ensure
that the results are representative of the target population studied, thereby avoiding the
potential biases detected by our study and others. Consent bias is of course just one of a
number of selection biases that may affect the generalisability of the results of observational
research. However, the effects of consent bias cannot always be predicted or quantified. In
the present study we were able to assess the potential for bias by comparison with a
contemporaneous clinical audit, but in the current research environment the possibility of
making such an assessment is increasingly unusual.
Although funding for clinically based research is limited,18 our study was reasonably well
resourced, with administrative, secretarial, programming, research nursing and laboratory
support, and help with recruitment from several consultants, specialist registrars and
research fellows. A considerable proportion of these resources was required specifically for
the consent process, although we did not formally record and quantify the time and costs
involved. Limitless resources might have enabled us to seek consent from almost all of those
eventually identified (both prospectively by the register mechanisms and subsequently via
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the audit), but this would have been neither realistic nor cost effective. Indeed, we believe
that the large amount of time and resources invested in obtaining explicit consent for the
inclusion of patients in observational studies such as ours could be better invested in
improving the quality and security of the data collected, better follow-up procedures, and in
gaining more research insights from the data collected, for example through add-on projects.
In addition, our anecdotal experience from encounters with large numbers of patients, as
well as our personal experience of consent for clinical observational research,19 suggests
that, for non-intrusive or minimally intrusive observational studies that could not
conceivably be associated with significant harm, the rather cumbersome consent process
itself can be an unnecessary intrusion in the clinical experience of vulnerable and often
frightened people, inappropriately shifting the focus away from their needs and care. Indeed,
we suggest that a system for clinical epidemiological studies in which all patients receiving
medical care are given the opportunity to refuse use of their clinical data, medical records
and clinical samples for research purposes, but explicit consent is not required, would
minimise bias and reduce the time and cost associated with the consent process. Thus,
consent would be implicit, and only patients specifically opting out would be excluded.
Allowing the use of implicit consent for more intrusive aspects of observational studies,
such as follow-up by questionnaire or the use of blood samples (as in our study), might be
regarded as controversial. However, a system of implicit consent (or often no consent at all)
operates for the large amount of unsolicited ‘junk mail’ that most of us receive daily, and
patients would be under no more obligation to complete and return a follow-up
questionnaire than they are to respond to unsolicited marketing surveys. A requirement for
explicit consent for taking additional blood samples for research purposes seems entirely
appropriate, but implicit consent for the research use of small volume blood samples taken at
the same time as those required in any case for clinical purposes would, in many cases,
avoid the need for additional invasive sampling specifically for research purposes.
The appropriateness and mechanics of such an opt-out system would vary, depending on the
patients, the disease and the study. Where considered appropriate, it would essentially
require that the patient (or their proxy) be provided with an information leaflet detailing the
information to be collected now and in the future (as is currently done in many hospitals
with respect to the use of data for clinical audit), to allow an informed choice to be made at
the time of clinical assessment or during hospitalisation, with a secure method for ensuring
that the wishes of those who opt out are documented and respected. Studies would naturally
still require scientific peer review and ethics committee approval, with full consideration of
any risk to or ramifications for the patients, and would have to be performed in line with
data protection laws and other relevant legislation.
A carefully designed opt-out system would not only increase participation and so reduce the
potential for consent bias, but would also allow valuable and limited resources to be diverted
from seeking explicit consent from potential participants and instead to improve the quality
of, and increase output from, observational clinical research. Data on refusal rates and
consent bias from studies such as ours, as well as studies demonstrating that research uses of
identifiable clinical data without explicit consent are acceptable to patients and potential
patients20, are needed to provide support for the view that more clinical observational
research studies should be able to proceed without explicit consent.
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Figure 1.
Flow diagram showing participation and non-participation in the research register
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Figure 2.
Participation rates among inpatients and outpatients
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Figure 3.
Distribution of event type by participation, for inpatients and outpatients TIA / Eye =
transient ischaemic attack or eye attack; LACS = lacunar stroke; PACS = partial anterior
circulation stroke; POCS = posterior circulation stroke; TACS = total anterior circulation
stroke; uncertain = uncertain stroke subtype
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Table 1
Statutory legislation and professional regulatory bodies issuing guidance relevant to
observational epidemiological research in the UK
Statutory legislation
Health and Social Care Act 2001 (England & Wales)2
Adults with Incapacity (Scotland) Act 20003
Mental Capacity Act 2005 (England & Wales)4
UK Data Protection Act 19985
UK Human Rights Act (1998)6
Human Tissue Act 2004 (England & Wales)7
Human Tissue (Scotland) Act 20068
Professional bodies
General Medical Council
Confidentiality & Security Advisory Group for Scotland
Medical Research Council
British Medical Association
Department of Health and its Patient Information Advisory Group
Royal Colleges of Physicians
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